Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron versus chlorpheniramine versus placebo for nausea control in adult emergency department patients
IRCT20230726058930N4Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nausea ((none)) comparing Ondansetron, Chlorpheniramine and Placebo (3 arms). Primary endpoint: nausea. Started Apr 2024; status: completed.
02
Drugs
ondansetronchlorpheniramine
03
Conditions
nausea ((none))
Beyond the preview
Go deeper on IRCT20230726058930N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230726058930N4.